Virtual Reality for Post Operative Pain (VRppain)
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT03776344 |
Recruitment Status :
Completed
First Posted : December 14, 2018
Last Update Posted : January 18, 2020
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Pain, Postoperative | Device: Virtual Reality intervention - Oculus Rift HD | Phase 2 |
Study Type : | Interventional (Clinical Trial) |
Actual Enrollment : | 62 participants |
Allocation: | Randomized |
Intervention Model: | Parallel Assignment |
Intervention Model Description: | We tested the efficacy of a VR environment in the treatment of pain after surgery. |
Masking: | Double (Participant, Care Provider) |
Masking Description: | As we had two groups in which one used a device for ensuring the masking the entire procedure was conducted in a separate room. |
Primary Purpose: | Treatment |
Official Title: | Efficacy of Virtual Reality for Post Operative Pain: A Randomized Controlled Trial |
Actual Study Start Date : | October 10, 2018 |
Actual Primary Completion Date : | July 31, 2019 |
Actual Study Completion Date : | September 30, 2019 |
Arm | Intervention/treatment |
---|---|
Experimental: Virtual Reality
Patients randomized to the experimental group will benefit from the usual standard care following surgery and during the second day the opportunity to use virtual reality for 15 minute. Along VR, they will complete the psychological and physiological measures.
|
Device: Virtual Reality intervention - Oculus Rift HD
During the VR experience patients will have the opportunity to choose from different VR environments (VR application - Nature Treks VR) and explore them using Oculus Rift Device. |
No Intervention: Non-VR condition (Standard of Care)
Patients randomized to the control group will benefit from the usual standard care following surgery and during the second day will complete the psychological and physiological measures.
|
- Pain intensity [ Time Frame: Pain intensity before intervention; Change from Baseline pain intensity (immediately following intervention) ]Graphic Rating Scale measure pain intensity from 1 to 10, 1 - no pain; 10 - worst pain.
- Pain intensity [ Time Frame: 5 minutes before intervention (baseline) ]Skin conductance response
- Pain intensity [ Time Frame: 15 minutes - During the intervention ]Skin conductance response
- Satisfaction with the intervention [ Time Frame: Immediately following intervention ]Patient Satisfaction Survey
- Presence in the VR environment [ Time Frame: Immediately following intervention ]Presence Inventory assesses the degree of spatial presence, involvement, ecological validity, overall presence, and negative effects experienced during the VR intervention
- Simulator Sickness [ Time Frame: Immediately following intervention ]Simulator Sickness Questionnaire
- Relaxation [ Time Frame: Relaxation level before intervention; Change from Baseline relaxation level (immediately following intervention) ]Graphic Rating Scale measure relaxation from 1 to 10, 1 - stressed; 10 - very relaxed.
- Time thinking about pain [ Time Frame: immediately following intervention ]Graphic Rating Scale measure the time spent thinking about pain from 1 to 10; 1 - not at all, 10 - all the time

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years to 65 Years (Adult, Older Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- Patient with varicose vein, hernia repair or gallbladder surgery
- Patient in the acute care units, 1-3 days following surgery.
- Willing and able to provide informed consent and participate in the study visit and study follow-up questionnaire.
Exclusion Criteria:
- Non-Romanian speaking patients.
- Age > 18 years and < 65 years.
- Patients with neoplastic pathologies.
- Patients with history of motion sickness.
- Patients with visual impairment.
- Patients with severe/profound cognitive impairments measured with Six-item Cognitive Impairment Test (6CIT).

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03776344
Romania | |
Municipal Hospital of Cluj-Napoca | |
Cluj-Napoca, Romania |
Responsible Party: | Raluca Georgescu, Phd student, Babes-Bolyai University |
ClinicalTrials.gov Identifier: | NCT03776344 |
Other Study ID Numbers: |
7150 |
First Posted: | December 14, 2018 Key Record Dates |
Last Update Posted: | January 18, 2020 |
Last Verified: | January 2020 |
Individual Participant Data (IPD) Sharing Statement: | |
Plan to Share IPD: | Yes |
Plan Description: | All collected data will be shared in an anonymized manner. |
Supporting Materials: |
Study Protocol Statistical Analysis Plan (SAP) Informed Consent Form (ICF) Clinical Study Report (CSR) |
Time Frame: | After the manuscript will be published. |
Studies a U.S. FDA-regulated Drug Product: | No |
Studies a U.S. FDA-regulated Device Product: | No |
Pain, Postoperative Postoperative Complications Pathologic Processes Pain Neurologic Manifestations |